Live from the NIH registry
Studies recruiting near Modesto right now
Top 25 of 102 recruiting studies, sorted by proximity — each links to its official registry page
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Memorial Medical Center — Modesto, California (0.3 mi)
· Sponsor: SWOG Cancer Research Network
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi)
· Sponsor: NRG Oncology
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Stockton Hematology Oncology Med Group — Stockton, California (27.1 mi)
· Sponsor: Paradigm Health
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Memorial Medical Center — Modesto, California (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Retinal Consultants Medical Group (Site 024) — Modesto, California (0.3 mi)
· Sponsor: EyeBiotech Ltd.
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Neovascular Age-related Macular Degeneration, nAMD
Phase 3
Interventional 304 participants sought
Retinal Consultants Medical Group, Inc.-Sacramento, Greenback Lane, (RCA) — Modesto, California (0.3 mi)
· Sponsor: Amgen
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Memorial Medical Center — Modesto, California (0.3 mi)
· Sponsor: NRG Oncology
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Paradigm Clinical Research - Modesto — Modesto, California (0.3 mi)
· Sponsor: vTv Therapeutics
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 306 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Phase 3
Interventional 975 participants sought
Retinal Consultants Medical Group Inc Modesto — Modesto, California (0.3 mi)
· Sponsor: Regeneron Pharmaceuticals
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study
Off Pump Coronary Artery Bypass Surgery
N/A
Observational 200 participants sought
St. Joseph's Medical Center Stockton — Stockton, California (27.1 mi)
· Sponsor: Maquet Cardiovascular
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
N/A
Interventional 535 participants sought
Saint Joseph's Medical Center — Stockton, California (27.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma
Phase 2
Interventional 152 participants sought
Memorial Medical Center — Modesto, California (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Memorial Medical Center — Modesto, California (0.3 mi)
· Sponsor: NRG Oncology
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Memorial Medical Center — Modesto, California (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma
Phase 2
Interventional 156 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Saint Joseph's Medical Center — Stockton, California (27.1 mi)
· Sponsor: NRG Oncology
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi)
· Sponsor: NRG Oncology
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Saint Joseph's Medical Center — Stockton, California (27.1 mi)
· Sponsor: SWOG Cancer Research Network
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 147 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
Effects of Energy Drinks on Cardiovascular Endpoints
Healthy Volunteers, Safety After Oral Intake
Phase 4
Interventional 3 participants sought
University of the Pacific — Stockton, California (27.1 mi)
· Sponsor: University of the Pacific